SB-743291 structure
|
Common Name | SB-743291 | ||
---|---|---|---|---|
CAS Number | 618430-39-0 | Molecular Weight | 517.058 | |
Density | 1.2±0.1 g/cm3 | Boiling Point | 683.0±55.0 °C at 760 mmHg | |
Molecular Formula | C31H33ClN2O3 | Melting Point | N/A | |
MSDS | N/A | Flash Point | 366.9±31.5 °C |
Use of SB-743291SB-743921 free base is a potent selective inhibitor of the mitotic kinesin KSP (Eg5), with a Ki of 0.1 nM. SB-743921 free base can induce mitotic arrest, block cell cycle progression, induce apoptosis, and can be used in the research of myeloma, leukemia and other diseases[1][2]. |
Name | 24DSZ1VN92 |
---|---|
Synonym | More Synonyms |
Description | SB-743921 free base is a potent selective inhibitor of the mitotic kinesin KSP (Eg5), with a Ki of 0.1 nM. SB-743921 free base can induce mitotic arrest, block cell cycle progression, induce apoptosis, and can be used in the research of myeloma, leukemia and other diseases[1][2]. |
---|---|
Related Catalog | |
In Vitro | SB-743921 是一种有效的 Eg5 抑制剂,Ki 为 0.1 nM[1]。 SB-743921 (1 nM) 有效抑制慢性粒细胞白血病 (CML) 原代细胞的集落形成细胞 (CFC) 形成,但对正常骨髓祖细胞的集落形成能力表现出轻微的抑制活性[2]。 SB-743921 (1-3 nM) 诱导 CML 原代 CD34+ 细胞凋亡,对正常 CD34+ 细胞有轻微影响。 SB-743921 与伊马替尼联合使用,在 KCL22 和 CML CD34+ 细胞中表现出附加的抗增殖作用。 此外,SB-743921 克服了 CML 细胞对伊马替尼的耐药性[2]。 SB-743921(0.5 nM、1 nM、3 nM)抑制 CML 细胞中的 MEK/ERK 和 AKT 信号传导[2]。 |
In Vivo | SB-743921 具有良好的口服生物利用度和药代动力学,可诱导携带肺癌患者异种移植物的裸鼠肿瘤完全消退[3]。 |
References |
Density | 1.2±0.1 g/cm3 |
---|---|
Boiling Point | 683.0±55.0 °C at 760 mmHg |
Molecular Formula | C31H33ClN2O3 |
Molecular Weight | 517.058 |
Flash Point | 366.9±31.5 °C |
Exact Mass | 516.217957 |
LogP | 6.79 |
Vapour Pressure | 0.0±2.1 mmHg at 25°C |
Index of Refraction | 1.613 |
N-(3-Aminopropyl)-N-[(1R)-1-(3-benzyl-7-chloro-4-oxo-4H-chromen-2-yl)-2-methylpropyl]-4-methylbenzamide |
24DSZ1VN92 |
Benzamide, N-(3-aminopropyl)-N-[(1R)-1-[7-chloro-4-oxo-3-(phenylmethyl)-4H-1-benzopyran-2-yl]-2-methylpropyl]-4-methyl- |